MarilynAngelaMcLaughlinMD
Hematology • York, MEMyeloproliferative Disorder Hematology-Oncology
Physician
Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Hospital Drive
York, ME 03909Phone+1 207-351-3777Fax+1 207-351-3788
Education & Training
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999- Westchester Medical CenterResidency, Internal Medicine, 1993 - 1996
Rutgers New Jersey Medical SchoolClass of 1993
Certifications & Licensure
ME State Medical License 2014 - 2026
NY State Medical License 1999 - 2025
NH State Medical License 2024 - 2024- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
- A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Start of enrollment: 2021 May 10
- The National Myelodysplastic Syndromes (MDS) Study Start of enrollment: 2016 Jun 13
Roles: Principal Investigator, Contact
Press Mentions
York Hospital CEO Dr. Patrick Taylor Meets with Local LeadersMay 11th, 2021- York Hospital Receives Zero COVID Shots This Week for Phase 1b RecipientsJanuary 26th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
